Provectus Biopharmaceuticals (PVCT) Cash from Financing Activities (2010 - 2025)
Provectus Biopharmaceuticals (PVCT) posted Cash from Financing Activities of $1.05 million for Q4 2025, up 33.0% from $788,419 a year earlier and up 111.4% from the prior quarter.
Provectus Biopharmaceuticals (PVCT) Cash from Financing Activities (2010 - 2025) Analysis & Trends
For FY2025, Provectus Biopharmaceuticals' Cash from Financing Activities came in at $3.09 million, up 12.3% from FY2024.
- Annual Cash from Financing Activities has increased for three consecutive years, though with a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- In prior years, Provectus Biopharmaceuticals' Cash from Financing Activities was $2.75 million in FY2024 (+25.4%), $2.19 million in FY2023 (+60.2%), $1.37 million in FY2022 (-66.0%) and $4.02 million in FY2021 (+11.8%).
- Quarterly Cash from Financing Activities has run from a low of -$33,527 in Q1 2022 to a high of $1.37 million in Q1 2021 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in four of the last eight quarters, with growth averaging 42.3%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q1 2021, with growth of 298.5%; the weakest was Q2 2021, with a decline of 81.9%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $495,903 (Q3 2025), $469,759 (Q2 2025) and $1.07 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 495,903.00 |
| Jun 30, 2025 | 469,759.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 788,419.00 |
| Sep 30, 2024 | 589,399.00 |
| Jun 30, 2024 | 588,952.00 |
| Mar 31, 2024 | 781,095.00 |
| Dec 31, 2023 | 201,552.00 |
| Sep 30, 2023 | 817,859.00 |
| Jun 30, 2023 | 656,441.00 |
| Mar 31, 2023 | 515,703.00 |
| Dec 31, 2022 | 474,158.00 |
| Sep 30, 2022 | 496,868.00 |
| Jun 30, 2022 | 430,342.00 |
| Mar 31, 2022 | -33,527.00 |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 404,292.00 |
| Mar 31, 2021 | 1.37 Mn |
Provectus Biopharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PVCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();